Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 2 (50%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PATEL, SAGAR S | 1 | 76.0% | +34.4% |
| BRISTOL, LYNN ANNE | 1 | 63.6% | +39.7% |
| KELLY, ROBERT M | 1 | 73.8% | +24.8% |
| DRISCOLL, MAUREEN VARINA | 1 | 64.2% | +43.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17909358 | GUIDANCE AND NAVIGATION CONTROL (GNC) ANTIBODY-LIKE PROTEINSAND METHODS OF MAKING AND USING THEREOF | DRISCOLL, MAUREEN VARINA | 168d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17909358 | GUIDANCE AND NAVIGATION CONTROL (GNC) ANTIBODY-LIKE PROTEINSAND METHODS OF MAKING AND USING THEREOF | DRISCOLL, MAUREEN VARINA | 168d overdue |
| 18030757 | Deuterated Camptothecin Derivative And Antibody-drug Conjugate Thereof | PATEL, SAGAR S | 72d overdue |
| 17909360 | MINIATURE GUIDANCE AND NAVIGATION CONTROL (miniGNC) ANTIBODY-LIKE PROTEINS AND METHODS OF MAKING AND USING THEREOF | KELLY, ROBERT M | 33d |
| 18027583 | EGFR BINDING COMPLEX AND METHOD OF MAKING AND USING THEREOF | BRISTOL, LYNN ANNE | — |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| 1643 | 1 |
| 1638 | 1 |
| 1644 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18030757 | Deuterated Camptothecin Derivative And Antibody-drug Conjugate Thereof | PATEL, SAGAR S | 1626 | §103§112DP | Final Rejection | 72d overdue | Pending | Apr 06, 2023 |
| 18027583 | EGFR BINDING COMPLEX AND METHOD OF MAKING AND USING THEREOF | BRISTOL, LYNN ANNE | 1643 | §112 | Final Rejection | — | Pending | Mar 21, 2023 |
| 17909360 | MINIATURE GUIDANCE AND NAVIGATION CONTROL (miniGNC) ANTIBODY-LIKE PROTEINS AND METHODS OF MAKING AND USING THEREOF | KELLY, ROBERT M | 1638 | §112 | Non-Final OA | 33d | Pending | Sep 03, 2022 |
| 17909358 | GUIDANCE AND NAVIGATION CONTROL (GNC) ANTIBODY-LIKE PROTEINSAND METHODS OF MAKING AND USING THEREOF | DRISCOLL, MAUREEN VARINA | 1644 | §103§112Other | Non-Final OA | 168d overdue | Pending | Sep 02, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial